Gan & Lee Pharmaceuticals Co Ltd (603087) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.01x

Gan & Lee Pharmaceuticals Co Ltd (603087) has a Cash Flow Reinvestment Rate of 1.01x as of September 2025, reinvesting CN¥260.89 Million (capex CN¥260.89 Million ) from operating cash flow of CN¥257.27 Million. Check Gan & Lee Pharmaceuticals Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.01x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥260.89 Million
Capex + Investments

Operating Cash Flow

CN¥257.27 Million
CNY

Capital Expenditures

CN¥260.89 Million
CNY

Gan & Lee Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for Gan & Lee Pharmaceuticals Co Ltd across 13 annual periods. Explore 603087 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)

Year-by-year capital reinvestment analysis for Gan & Lee Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see Gan & Lee Pharmaceuticals Co Ltd market capitalisation.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.01x CN¥1.58 Billion CN¥784.28 Million CN¥926.09 Million ▲ +75.2%
2024 1.15x CN¥616.97 Million CN¥537.31 Million CN¥440.80 Million ▼ -67.9%
2023 3.58x CN¥1.53 Billion CN¥427.69 Million CN¥553.06 Million ▼ -19.1%
2022 4.42x CN¥1.31 Billion CN¥296.68 Million CN¥983.44 Million ▲ +535.4%
2021 0.70x CN¥750.31 Million CN¥1.08 Billion CN¥692.08 Million ▼ -73.4%
2020 2.61x CN¥3.24 Billion CN¥1.24 Billion CN¥582.14 Million ▲ +139.7%
2019 1.09x CN¥1.26 Billion CN¥1.15 Billion CN¥406.63 Million ▼ -31.2%
2018 1.59x CN¥662.64 Million CN¥418.04 Million CN¥513.44 Million ▲ +103.0%
2017 0.78x CN¥741.52 Million CN¥949.60 Million CN¥431.02 Million ▼ -5.1%
2016 0.82x CN¥633.34 Million CN¥769.63 Million CN¥258.48 Million ▼ -0.1%
2015 0.82x CN¥368.43 Million CN¥447.42 Million CN¥368.43 Million ▼ -20.3%
2014 1.03x CN¥315.47 Million CN¥305.22 Million CN¥315.47 Million ▲ +111.5%
2013 0.49x CN¥100.06 Million CN¥204.73 Million CN¥100.06 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow